Zobrazeno 1 - 10 of 638 pro vyhledávání: '"Rossenu S"'
1
Akademický článek
Translational population target binding model for the anti-FcRn fragment antibody efgartigimod.
Autor: Hoefman S; LAP&P Consultants BV, Archimedesweg 31, Leiden, CM 2333, The Netherlands. S.Hoefman@lapp.nl., van Steeg T; LAP&P Consultants BV, Archimedesweg 31, Leiden, CM 2333, The Netherlands., Ottevaere I; Argenx BV, Industriepark Zwijnaarde 7, Zwijnaarde, 9052, Belgium., Baumeister J; Argenx BV, Industriepark Zwijnaarde 7, Zwijnaarde, 9052, Belgium., Rossenu S; Argenx BV, Industriepark Zwijnaarde 7, Zwijnaarde, 9052, Belgium.
Publikováno v: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Dec 05; Vol. 52 (1), pp. 2. Date of Electronic Publication: 2024 Dec 05.
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Using Model-Based "Learn and Confirm" to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial.
Autor: Elassaiss‐Schaap, J1,2 jeroen@pd-value.com, Rossenu, S1,3, Lindauer, A1,4, Kang, SP1, de Greef, R4,5, Sachs, JR1, de Alwis, DP1
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. Jan2017, Vol. 6 Issue 1, p21-28. 8p.
Zobrazit plný text záznamu
7
Akademický článek
A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study.
Autor: O'Neil B; Wayne State University School of Medicine, Detroit Medical Center, Detroit, Michigan, USA., Ison MG; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Hallouin-Bernard MC; University Hospital of Tours, Tours, France., Nilsson AC; Infectious Disease Research Unit, Department of Translational Medicine, Skåne University Hospital, Malmö, Sweden., Torres A; Servei de Pneumologia Hospital Clinic, August Pi i Sunyer Biomedical Research Institute, Biomedical Research Networking Center on Respiratory Diseases, University of Barcelona, Barcelona, Spain., Wilburn JM; Wayne State University School of Medicine, Detroit Medical Center, Detroit, Michigan, USA., van Duijnhoven W; Janssen Pharmaceutica NV, Beerse, Belgium., Van Dromme I; Janssen Pharmaceutica NV, Beerse, Belgium., Anderson D; Janssen Research and Development, LLC, Titusville, New Jersey, USA., Deleu S; Janssen Pharmaceutica NV, Beerse, Belgium., Kosoglou T; Janssen Research and Development, LLC, Titusville, New Jersey, USA., Vingerhoets J; Janssen Pharmaceutica NV, Beerse, Belgium., Rossenu S; Janssen Pharmaceutica NV, Beerse, Belgium., Leopold L; Janssen Research and Development, LLC, Titusville, New Jersey, USA.
Publikováno v: The Journal of infectious diseases [J Infect Dis] 2022 Aug 12; Vol. 226 (1), pp. 109-118.
Zobrazit plný text záznamu
8
Using Model‐Based 'Learn and Confirm' to Reveal the Pharmacokinetics‐Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE‐001 Trial
Autor: Elassaiss‐Schaap, J, Rossenu, S, Lindauer, A, Kang, SP, de Greef, R, Sachs, JR, de Alwis, DP
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology
Evaluation of pharmacokinetic/pharmacodynamic (PK/PD) properties played an important role in the early clinical development of pembrolizumab. Because analysis of data from a traditional 3 + 3 dose‐escalation design revealed several critical uncerta
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1bd2e852be4989d509c2c680d72355e7
http://europepmc.org/articles/PMC5270295
Zobrazit plný text záznamu
9
Akademický článek
Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug-resistant tuberculosis.
Autor: Tanneau L; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Svensson EM; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Rossenu S; Department Clinical Pharmacology and Pharmacometrics, Janssen Pharmaceutica NV, Beerse, Belgium., Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Dec; Vol. 10 (12), pp. 1538-1549. Date of Electronic Publication: 2021 Oct 22.
Zobrazit plný text záznamu
10
Akademický článek
Population Pharmacokinetic Analysis of Bedaquiline-Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study.
Autor: Kurosawa K; Department of Clinical Pharmacology, Janssen Pharmaceutical KK, Tokyo, Japan., Rossenu S; Janssen Research and Development, Beerse, Belgium., Biewenga J; Janssen Research and Development, Beerse, Belgium., Ouwerkerk-Mahadevan S; Janssen Research and Development, Beerse, Belgium., Willems W; Janssen Research and Development, Beerse, Belgium., Ernault E; Janssen Research and Development, Beerse, Belgium., Kambili C; Johnson and Johnson Services, Inc, New Brunswick, New Jersey, USA.
Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2021 Oct; Vol. 61 (10), pp. 1344-1355. Date of Electronic Publication: 2021 Jun 12.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje